Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02482701 · ClinicalTrials.gov registry record
The Captivator EMR Registry
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 291
- Enrollment target
NCT02482701: Completed study, sponsored by Boston Scientific Corporation.
NCT02482701 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 291 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02482701 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 291 participants
- Enrollment target
Study Summary
To confirm performance of the Captivator™ EMR device for resection of early neoplasia in Barrett's Esophagus.
Primary Outcome
Successful resection is assessed during the EMR procedure
Interventions
- DEVICE Captivator™ EMR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 291 participants |
| Start Date | 2015-08 |
| Est. Completion | 2017-06 |
What the finished NCT02482701 record still lists
NCT02482701 is an observational study that tracks outcomes without assigning an intervention. The registered 291 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Captivator™ EMR is the first listed.
NCT02482701 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02482701 about?
NCT02482701 is a clinical study titled "The Captivator EMR Registry". To confirm performance of the Captivator™ EMR device for resection of early neoplasia in Barrett's Esophagus.
What is the current status of trial NCT02482701?
This trial is currently completed. The enrollment target is 291 participants. The study started on 2015-08. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02482701?
The interventions under investigation include: Captivator™ EMR (DEVICE).
Who is sponsoring clinical trial NCT02482701?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02074839 · 291 participants · Phase 1
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
- NCT03769766 · 291 participants · Phase 3
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
- NCT06563479 · 291 participants · Phase 3
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
- NCT04429542 · 292 participants · Phase 1
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia